Security key
00887A204
Rein Therapeutics, Inc. - Common Stock, $0.001 par value (RNTX)
CUSIP: 00887A204
Q2 2024 13F Holders as of 30 Jun 2024
- Security type / class
- Equity / Common Stock, $0.001 par value
- Total 13F shares
- 4,894,669
- Total 13F value
- $13,494,162
- Share change
- +3,206,219
- SEC-reported price per share
- $2.77
- Number of holders
- 27
- Value change
- +$5,623,418
- Number of buys
- 18
- Number of sells
- 7
- Shares outstanding
- 85,711,470
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2024
Institutions
27
Top holders
10
RNTX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Rein Therapeutics, Inc. SEC filings
Rein Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 00887A204
Recent filing periods:
Ownership snapshot
Top reported holders of RNTX - Rein Therapeutics, Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Alerce Investment Managem...
Disclosed value leader
Alerce Investment Managem...
Comparable rows
15/15
Latest evidence
31 Mar 2024
13F
Lead comparable stake: 0.97%
Showing 1-6 of 15 holder rows.
Quick read
Alerce Investment Management, L.P. leads the comparable SEC ownership view at 0.97%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Alerce Investment Management, L.P.'s linked filing trail.
Comparable ownership
Top 5
Alerce Investment Management, L.P.
0.97%
Nantahala Capital Management, LLC
0.3%
Senvest Management, LLC
0.27%
GEODE CAPITAL MANAGEMENT, LLC
0.08%
Sigma Planning Corp
0.08%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Alerce Investment Management, L.P. |
13F
Company
|
0.97%
|
$5,505,990
830,466 shares
|
— | 31 Mar 2024 |
| Nantahala Capital Management, LLC |
13F
Company
|
0.3%
|
$1,690,650
255,000 shares
|
— | 31 Mar 2024 |
| Senvest Management, LLC |
13F
Company
|
0.27%
|
$1,301,209
230,895 shares
|
— | 31 Mar 2024 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.08%
|
$453,433
69,759 shares
|
— | 31 Mar 2024 |
| Sigma Planning Corp |
13F
Company
|
0.08%
|
$450,741
67,985 shares
|
— | 31 Mar 2024 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
0.05%
|
$299,000
45,064 shares
|
— | 31 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
27
Shares
4,894,669
Rows available
27
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2024 vs Q1 2026 Across Filers
Q1 2026 holders
45
Q2 2024 holders
27
Holder diff
-18
| Investor | Q1 2026 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend